Senseonics Holdings SENS
NASDAQ SENS
$8.72 -0.61 (-6.55%)
As of: Sep 9, 2026 · 3:59 PM EDT

Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026)

Senseonics Holdings' (SENS) quarterly Liabilities and Shareholders Equity came in at $176.8 million in Q2 2026, up 17.68% year-over-year from $150.3 million in Q2 2025, and up 71.92% quarter-over-quarter from $102.9 million in Q1 2026.

Analysis

Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Senseonics Holdings (SENS) has reported Liabilities and Shareholders Equity for 13 consecutive years, with $176.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 17.68% year-over-year to $176.8 million in Q2 2026; TTM through Jun 2026 was $545.9 million, a 25.71% increase from a year earlier, with the FY2025 full-year figure at $126.3 million, up 25.72% from the prior year.
  • Liabilities and Shareholders Equity was $176.8 million for Q2 2026 at Senseonics Holdings, up from $102.9 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $188.1 million in Q1 2022 and troughed at $87.2 million in Q1 2025.
  • A 5-year average of $141.5 million and a median of $145.1 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity slumped 37.47% in 2024 and jumped 45.25% in 2025, its largest moves.
  • Over 5 years, Liabilities and Shareholders Equity stood at $177.7 million in 2022, then dropped by 22.21% to $138.2 million in 2023, then dropped by 27.33% to $100.4 million in 2024, then gained by 25.72% to $126.3 million in 2025, then surged by 40.05% to $176.8 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $176.8 million (Q2 2026), $102.9 million (Q1 2026), and $126.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 20.88 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 93.31 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 13.87 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 31.10 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 6.46 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 10.74 Bn
10 Senseonics Holdings 507.86 Mn 267.25 Mn 8.56 Mn 176.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 176.84 Mn
Mar 31, 2026 102.86 Mn
Dec 31, 2025 126.27 Mn
Sep 30, 2025 139.92 Mn
Jun 30, 2025 150.27 Mn
Mar 31, 2025 87.21 Mn
Dec 31, 2024 100.44 Mn
Sep 30, 2024 96.33 Mn
Jun 30, 2024 111.56 Mn
Mar 31, 2024 126.52 Mn
Dec 31, 2023 138.22 Mn
Sep 30, 2023 154.07 Mn
Jun 30, 2023 153.36 Mn
Mar 31, 2023 158.53 Mn
Dec 31, 2022 177.67 Mn
Sep 30, 2022 182.67 Mn
Jun 30, 2022 175.33 Mn
Mar 31, 2022 188.10 Mn
Dec 31, 2021 198.93 Mn
Sep 30, 2021 219.62 Mn